期 |
栏目 |
标题 |
文件 |
卷 21, 编号 4 (2019) |
CLINICAL ONCOLOGY |
Long-term results of surgical treatment of patients with retroperitoneal leiomyosarcoma |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Metastatic gastrointestinal stromal tumor of the greater omentum. Case report |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Surgical treatment of recurrent ovarian cancer: A review |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Activation of the PI3K-AKT-mTOR cascade in uterine leiomyosarcoma: a retrospective study of 31 patients |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Gastric cancer: Russian clinical guidelines |
(Rus)
|
卷 24, 编号 1 (2022) |
CLINICAL ONCOLOGY |
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer |
(Rus)
|
卷 24, 编号 2 (2022) |
CLINICAL ONCOLOGY |
Modern strategy of treatment of patients with retroperitoneal sarcomas: A review |
(Rus)
|
卷 24, 编号 2 (2022) |
CLINICAL ONCOLOGY |
Recurrent of ovarian cancer with lymph node involvement: surgery or chemotherapy? Retrospective cohort study |
(Rus)
|
卷 24, 编号 3 (2022) |
CLINICAL ONCOLOGY |
The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study |
(Rus)
|
卷 25, 编号 2 (2023) |
CLINICAL ONCOLOGY |
Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study |
(Rus)
|
卷 26, 编号 2 (2024) |
Articles |
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data |
(Rus)
|